Literature DB >> 20827361

The Treatment of Patients With Irritable Bowel Syndrome: Review of the Latest Data From the 2010 DDW Meeting.

Mark Pimentel1.   

Abstract

Entities:  

Year:  2010        PMID： 20827361      PMCID： PMC2933753     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  30 in total

Review 1.  An evidence-based position statement on the management of irritable bowel syndrome.

Authors:  Lawrence J Brandt; William D Chey; Amy E Foxx-Orenstein; Lawrence R Schiller; Philip S Schoenfeld; Brennan M Spiegel; Nicholas J Talley; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

2.  Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort.

Authors:  F Cremonini; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2006-11       Impact factor: 3.598

3.  Postinfectious irritable bowel syndrome--a meta-analysis.

Authors:  Heather A Halvorson; Carey D Schlett; Mark S Riddle
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

Review 4.  Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance.

Authors:  S M Collins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-03       Impact factor: 4.052

5.  The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants.

Authors:  Rona L Levy; Jennifer A Linde; Kayla A Feld; Michael D Crowell; Robert W Jeffery
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

6.  Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.

Authors:  G Battaglia; A M Morselli-Labate; E Camarri; A Francavilla; F De Marco; G Mastropaolo; R Naccarato
Journal:  Aliment Pharmacol Ther       Date:  1998-10       Impact factor: 8.171

7.  Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass.

Authors:  Ronald H Clements; Quintin H Gonzalez; Allen Foster; William O Richards; James McDowell; Anthony Bondora; Henry L Laws
Journal:  Obes Surg       Date:  2003-08       Impact factor: 4.129

Review 8.  Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome.

Authors:  Henry C Lin
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

9.  Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.

Authors:  F Baldi; A Longanesi; A Blasi; S Monello; R Cestari; G Missale; E Corazziari; G Badiali; M Pescatori; G Anastasio
Journal:  Ital J Gastroenterol       Date:  1991-11

10.  Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Yoshihiro Fukuda; Masakazu Takazoe; Akira Sugita; Tadashi Kosaka; Fukunori Kinjo; Yoshimasa Otani; Hisao Fujii; Kazutaka Koganei; Kazuya Makiyama; Toshio Nakamura; Takeyasu Suda; Shojiro Yamamoto; Toshifumi Ashida; Akira Majima; Norikazu Morita; Kazunari Murakami; Nobuhide Oshitani; Kazuya Takahama; Masahiro Tochihara; Tomoyuki Tsujikawa; Makoto Watanabe
Journal:  Am J Gastroenterol       Date:  2008-07-04       Impact factor: 10.864
View more
  1 in total

1.  Characteristics of deslanoside-induced modulation on jejunal contractility.

Authors:  Da-Peng Chen; Yong-Jian Xiong; Ze-Yao Tang; Qi-Ying Yao; Dong-Mei Ye; Sha-Sha Liu; Yuan Lin
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.